Skip to content

Modification of Attentional Bias to Emotional Faces Following Mindfulness-Based Cognitive Therapy in People with a Current Depression

Paweł Holas, Izabela Krejtz, Katarzyna Wisiecka, Marzena Rusanowska, John B. Nezlek

Mindfulness June 1, 2020 DOI: 10.1007/s12671-020-01353-2 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 53
Population Individuals with current major depressive disorder
Intervention Mindfulness-based cognitive therapy
Duration 8-week intervention
Topics Depression Meditation
Key findings MBCT reduced depression symptoms and shifted attentional bias away from sad faces and toward happy faces in currently depressed individuals.

Abstract

Abstract Objectives Mindfulness-based cognitive therapy (MBCT) is an evidence-based treatment to prevent relapse in individuals with recurrent major depressive disorder (MDD). It is not clear if MBCT is an effective therapy for current depression, and it is not clear what mechanisms are responsible for the effectiveness of MBCT. Theoretically, MBCT is believed to modify the processing of emotional information and reduce cognitive vulnerability to depression; however, it is not clear if MBCT leads to normalization of attentional biases in depressed individuals. The aim of the current study was to determine if MBCT can modify some of the attentional biases underlying depression in MDD.

Methods: Participants were 53 individuals with diagnosis of current MDD. They were randomly assigned to either MBCT (n = 25) or wait list control group (n = 28) condition. Before and after the 8-week MBCT intervention participants completed the Center for Epidemiological Studies Depression scale (CESD), they viewed slides presenting sad, angry, happy, and neutral facial expressions, and their eye movements were recorded during the viewing task.

Results: As expected, compared to participants in the control group, the CESD scores of participants who received MBCT decreased following treatment, their attention to sad faces decreased, and their attention to happy faces increased. Moreover, cross-lagged analysis suggested a causal link from changes in attentional bias to changes in depression.

Conclusions: We found that MBCT can modify the attentional processing of emotional facial stimuli and that attentional bias modification may translate into clinical improvement in currently depressed individuals.

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 7

and 2 more in the library

Cites 25

and 20 more in the library

Explore topics